How can BioMed possibly say that NuVax would be worth a ton of money when RPC does not even own the patent for CIT. A Canadian court ordered that all rights to the patent be transferred from RPC to AccuVector and also Dr. Chang transfer any rights he has remaining back to Accuvector.
RPC keeps saying the lawsuit will be settled but so far, claimed dates for settlement come and go.
No company is going to invest money in a technology they do not own. Also, there is no indication that Gaur Diagno or Javia Technologies has any funding at all to develop CIT.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.
